Best Hospitals for Total Anomalous Pulmonary Venous Connection (TAPVC) in Delhi NCR, India
35 paediatric cardiology hospitals in our India network are listed in Delhi NCR, accredited by JCI, NABH, NABL, ISO, with 17,362 beds combined.
This page lists the paediatric cardiology hospitals in our directory offering Total Anomalous Pulmonary Venous Connection (TAPVC) in Delhi NCR, India, including Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute and others. Each listing links through to the hospital's full profile page.
Ask us about total anomalous pulmonary venous connection (tapvc) in Delhi NCR, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 35 accredited hospitals for Paediatric Cardiology in Delhi NCR, India
Featured🇮🇳 Apollo Hospitals
Ranks #1 in this list by listed rating (4.9/5 from 1240 reviews).
🇮🇳 Medanta - The Medicity
Ranks #2 in this list by listed rating (4.9/5 from 2150 reviews).
🇮🇳 Artemis Hospital
Ranks #3 in this list by listed rating (4.9/5 from 64 reviews).
🇮🇳 Fortis Memorial Research Institute
Ranks #4 in this list by listed rating (4.8/5 from 1100 reviews).
🇮🇳 Max Super Specialty Hospital
Ranks #5 in this list by listed rating (4.8/5 from 1300 reviews).
🇮🇳 All India Institute of Medical Sciences (AIIMS)
Ranks #6 in this list by listed rating (4.7/5 from 3500 reviews).
🇮🇳 CK Birla Hospital
Ranks #7 in this list by listed rating (4.7/5 from 162 reviews).
🇮🇳 Centre for Sight
Ranks #8 in this list by listed rating (4.7/5 from 181 reviews).
🇮🇳 Max Super Specialty Hospital, Gurgaon
Ranks #9 in this list by listed rating (4.6/5 from 95 reviews).
🇮🇳 Max Super Speciality Hospital, Patparganj
Ranks #10 in this list by listed rating (4.6/5 from 97 reviews).
🇮🇳 Primus Super Speciality Hospital
Ranks #11 in this list by listed rating (4.6/5 from 142 reviews).
🇮🇳 PSRI Multispeciality Hospital
Ranks #12 in this list by listed rating (4.6/5 from 318 reviews).
🇮🇳 Fortis Hospital, Shalimar Bagh
Ranks #13 in this list by listed rating (4.5/5 from 68 reviews).
🇮🇳 Sarvodaya Hospital
Ranks #14 in this list by listed rating (4.5/5 from 74 reviews).
🇮🇳 Indian Spinal Injuries Center
Ranks #15 in this list by listed rating (4.5/5 from 76 reviews).
🇮🇳 Max Super Speciality Hospital, Shalimar Bagh
Ranks #16 in this list by listed rating (4.5/5 from 82 reviews).
🇮🇳 Fortis Hospital, Noida
Ranks #17 in this list by listed rating (4.5/5 from 88 reviews).
🇮🇳 Venkateshwar Hospital
Ranks #18 in this list by listed rating (4.5/5 from 69 reviews).
🇮🇳 CK Birla Hospital
Ranks #19 in this list by listed rating (4.5/5 from 72 reviews).
🇮🇳 Fortis Flt. Lt. Rajan Dhall Hospital
Ranks #20 in this list by listed rating (4.5/5 from 75 reviews).
🇮🇳 Asian Institute of Medical Sciences
Ranks #21 in this list by listed rating (4.5/5 from 119 reviews).
🇮🇳 Manipal Hospitals Dwarka
Ranks #22 in this list by listed rating (4.4/5 from 54 reviews).
🇮🇳 Sir Ganga Ram Hospital
Ranks #23 in this list by listed rating (4.4/5 from 24 reviews).
🇮🇳 Fortis Escorts Hospital
Ranks #24 in this list by listed rating (4.4/5 from 31 reviews).
🇮🇳 Marengo Asia Hospitals
Ranks #25 in this list by listed rating (4.4/5 from 54 reviews).
🇮🇳 Yatharth Super Specialty Hospital
Ranks #26 in this list by listed rating (4.4/5 from 61 reviews).
🇮🇳 Paras Hospitals
Ranks #27 in this list by listed rating (4.4/5 from 59 reviews).
🇮🇳 Fortis Hospital Manesar
Ranks #28 in this list by listed rating (4.4/5 from 74 reviews).
🇮🇳 Marengo Asia Hospitals Gurgaon
Ranks #29 in this list by listed rating (4.4/5 from 103 reviews).
🇮🇳 Metro Hospital Noida
Ranks #30 in this list by listed rating (4.4/5 from 121 reviews).
🇮🇳 Sharda Hospital
Ranks #31 in this list by listed rating (4.4/5 from 130 reviews).
🇮🇳 Fortis Hospital, Greater Noida
Ranks #32 in this list by listed rating (4.3/5 from 28 reviews).
🇮🇳 Fortis Escorts Hospital Jaipur
Ranks #33 in this list by listed rating (4.3/5 from 132 reviews).
🇮🇳 Max Super Speciality Hospital, Saket
Ranks #34 in this list by listed rating (3.8/5 from 49 reviews).
🇮🇳 BLK-Max Super Speciality Hospital
Ranks #35 in this list by listed rating (3.8/5 from 48 reviews).
How we selected these hospitals
A hospital appears on this page when Paediatric Cardiology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Total Anomalous Pulmonary Venous Connection (TAPVC) in Delhi NCR, India?
Choosing the right hospital for total anomalous pulmonary venous connection (tapvc) is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include paediatric cardiology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Total Anomalous Pulmonary Venous Connection (TAPVC)
Total Anomalous Pulmonary Venous Connection (TAPVC) repair is an open-heart surgical procedure performed in neonates and infants to redirect all four pulmonary veins—which abnormally drain into the systemic venous circulation rather than the left atrium—back into their correct anatomical pathway, restoring oxygenated blood flow to the body. With specialized pediatric cardiac surgery centers in India and the UAE achieving overall survival rates exceeding 90–95% for non-obstructed TAPVC subtypes, and cardiopulmonary bypass and deep hypothermic circulatory arrest (DHCA) techniques now highly refined, outcomes rival those of leading centers in North America and Europe at a fraction of the cost. GAF Healthcare connects international families to JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centers in Dubai and Abu Dhabi, managing every step from diagnostic review and surgical scheduling to post-operative follow-up and repatriation logistics. Hospital Stay: 10–18 days (including 4–7 days in Pediatric Cardiac Intensive Care Unit, followed by stepdown ward observation) • Total Stay in Country (Fit-to-Fly): 4–6 weeks post-surgery (international flight clearance requires stable hemodynamics, closed sternum, no pleural effusion, and a final echocardiographic assessment confirming unobstructed pulmonary venous drainage) • Success Rate: 90–95% overall surgical survival; >85% freedom from reoperation at 5 years for supracardiac and cardiac subtypes; ~80–88% for infracardiac and mixed subtypes
Clinical Overview
Total Anomalous Pulmonary Venous Connection (TAPVC) is a rare but critical cyanotic congenital heart defect in which all four pulmonary veins fail to connect to the left atrium during embryonic development, instead draining into the right atrium or its tributaries—most commonly the superior vena cava, coronary sinus, portal vein, or ductus venosus. Because no oxygenated blood enters the left heart directly, survival depends entirely on the presence of an interatrial communication (patent foramen ovale or atrial septal defect) through which mixed blood passes to the left side. The resulting physiology is one of obligate right-to-left shunting, progressive right ventricular volume overload, pulmonary hypertension, and—when the pulmonary venous confluence is obstructed (as occurs in infracardiac TAPVC)—acute, life-threatening pulmonary venous hypertension and edema that constitutes a neonatal surgical emergency. The Darling classification system stratifies TAPVC into four anatomical subtypes: Type I (supracardiac, ~45% of cases, draining via vertical vein to the innominate vein or superior vena cava), Type II (cardiac, ~25%, draining into the coronary sinus or right atrium directly), Type III (infracardiac, ~25%, draining below the diaphragm via the portal or hepatic venous system), and Type IV (mixed, ~5%, with drainage at multiple levels). Obstructed TAPVC—most prevalent in the infracardiac form—presents within hours to days of birth with severe cyanosis, tachypnea, and pulmonary edema on chest radiography, and demands emergent surgical correction without delay. Non-obstructed forms may present more insidiously over weeks with failure to thrive, recurrent respiratory infections, and progressive cyanosis detected on pulse oximetry screening. The current standard of care is complete surgical repair using cardiopulmonary bypass (CPB) with or without deep hypothermic circulatory arrest (DHCA), typically performed in the first days to weeks of life. The surgical objective is to create a wide, tension-free anastomosis between the common pulmonary venous confluence and the posterior left atrium, ligate the anomalous venous connection, and close the interatrial communication. Long-term outcomes are favorable for most subtypes, though postoperative pulmonary venous obstruction (PVO)—occurring in 5–18% of cases—remains the most feared complication and may necessitate reintervention via sutureless (pericardium-in-situ) repair techniques, transcatheter balloon dilation, or hybrid procedures. Modern high-volume pediatric cardiac centers track outcomes using the Society of Thoracic Surgeons Congenital Heart Surgery (STS-CHS) database, with mortality benchmarks, procedure complexity scores, and risk-stratified survival curves guiding institutional quality improvement.
Who is a Candidate?
• Confirmed TAPVC of any Darling subtype (I–IV), diagnosed via transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), cardiac CT angiography (CCTA), or cardiac MRI • Neonates, infants, and young children with obstructed TAPVC presenting as a surgical emergency (emergent indication regardless of weight or gestational maturity) • Non-obstructed TAPVC patients with progressive cyanosis (SpO2 persistently <85%), right ventricular dilation, or pulmonary-to-systemic flow ratio (Qp:Qs) >1.5:1 detected on cardiac catheterization or Doppler echocardiography • Infants with failure to thrive, recurrent lower respiratory tract infections, or pulmonary hypertension attributable to TAPVC physiology • Mixed TAPVC (Type IV) requiring staged or simultaneous multi-level repair, planned in conjunction with a multidisciplinary pediatric cardiac team Required Diagnostic Workup Prior to Surgical Referral: • Two-dimensional and color-flow Doppler transthoracic echocardiography (TTE): definitive identification of pulmonary vein drainage anatomy, assessment of venous obstruction gradient (>3 mmHg is clinically significant), right ventricular function, pulmonary artery pressure estimation, and atrial septal defect sizing • Cardiac CT Angiography (CCTA) with 3D reconstruction: gold standard for delineating the spatial relationship of the pulmonary venous confluence, vertical vein, and systemic venous connections, particularly in complex mixed or infracardiac types • Cardiac MRI (where infant weight and clinical stability permit): quantification of Qp:Qs ratio, right ventricular volumes, and ventricular function without radiation • Chest X-ray: classic 'figure-of-8' or 'snowman' silhouette in supracardiac TAPVC; pulmonary venous congestion pattern in obstructed infracardiac TAPVC • Arterial blood gas (ABG): severity of hypoxemia, metabolic acidosis • Complete blood count, comprehensive metabolic panel, coagulation studies (PT/aPTT/fibrinogen), and blood type and crossmatch • Cardiac catheterization with hemodynamic assessment: reserved for complex or mixed cases where echocardiography and CCTA are inconclusive, or to measure precise pulmonary vascular resistance index (PVRI) prior to repair • Preoperative prostaglandin E1 (PGE1) infusion: indicated in critically obstructed TAPVC to maintain ductal patency and improve systemic perfusion while awaiting emergent surgery Contraindications and High-Risk Considerations: • Severe, fixed pulmonary arterial hypertension with pulmonary vascular resistance index (PVRI) >8–10 Wood units·m² unresponsive to vasodilator challenge (relative contraindication; may require medical optimization with sildenafil, iloprost, or inhaled nitric oxide prior to surgery) • Extreme prematurity (<28 weeks gestational age) or birth weight <1,500 g: increased procedural risk; multidisciplinary consensus required; may require bridging strategies • Concomitant non-cardiac major congenital anomalies or genetic syndromes with limited survival prognosis • Active systemic sepsis or uncontrolled coagulopathy not correctable prior to surgery (relative contraindication; emergent repair may still be life-saving in obstructed TAPVC) • Severe, irreversible end-organ dysfunction (hepatic failure in infracardiac TAPVC with prolonged obstruction)
Treatment Options & Approaches
TAPVC repair is exclusively a surgical procedure; there is no catheter-based or medical definitive treatment. However, the operative approach, adjuncts, and reintervention strategies have evolved substantially. 1. Standard Open Surgical Repair (Primary Approach — All Subtypes) The foundational technique involves median sternotomy, institution of cardiopulmonary bypass (CPB) using aortic and bicaval cannulation, and cardiac arrest with cold crystalloid or blood cardioplegia. Deep hypothermic circulatory arrest (DHCA) at core temperatures of 18–20°C is employed for neonates and small infants to provide a bloodless operative field, with cerebral perfusion protection strategies (antegrade cerebral perfusion via right axillary artery or direct cannulation of the innominate artery) increasingly used to reduce neurological injury associated with DHCA. • Supracardiac TAPVC (Type I): The common pulmonary venous confluence is exposed posterior to the heart. A wide side-to-side anastomosis is created between the posterior wall of the left atrium and the anterior wall of the confluence using absorbable suture (polydioxanone or polyglycolic acid) or fine polypropylene. The vertical vein is ligated at its junction with the innominate vein or superior vena cava. The atrial septal defect or patent foramen ovale is closed with a pericardial patch or direct suture. • Cardiac TAPVC (Type II, coronary sinus type): The roof of the coronary sinus is unroofed and the atrial septal defect is patched so that the coronary sinus opening drains into the left atrium, redirecting all pulmonary venous return to the left side. Care is taken to avoid injury to the atrioventricular node and coronary sinus orifice. • Infracardiac TAPVC (Type III): This subtype typically presents as an emergency. The common pulmonary venous confluence is mobilized from the descending vertical vein. A generous posterior left atrial anastomosis is constructed, and the descending vertical vein is ligated at the level of the diaphragm. Right atriotomy is performed for ASD closure. The proximity of the descending vein to the esophagus and thoracic duct demands meticulous dissection. • Mixed TAPVC (Type IV): Requires individualized planning; may involve simultaneous repair of multiple drainage levels or a staged approach. Intraoperative TEE is mandatory to confirm anastomotic adequacy and residual obstruction prior to decannulation. 2. Sutureless (Pericardium-In-Situ) Repair Technique Originated by Lacour-Gayet and now widely adopted for cases at high risk of postoperative pulmonary venous obstruction (PVO), the sutureless technique avoids suturing directly on pulmonary vein tissue—which is prone to intimal proliferation and restenosis. Instead, the pericardial sac surrounding the pulmonary veins is used as the posterior wall of the anastomosis; the left atrial wall is sutured to the pericardium at a distance from the pulmonary vein ostia, creating a wide, suture-free channel. This approach is now the preferred primary strategy at many high-volume centers for infracardiac TAPVC and for any TAPVC with venous obstruction, due to significantly lower rates of postoperative PVO (2–5% vs. 10–18% with conventional repair) and superior freedom from reoperation at 5 years. 3. Management of Postoperative Pulmonary Venous Obstruction (PVO) Residual or recurrent PVO following primary repair is the most challenging complication in TAPVC management. • Surgical revision with sutureless technique: Preferred approach for anatomically accessible obstruction; involves excision of obstructing fibrous tissue and conversion to or repeat sutureless anastomosis. • Transcatheter interventions: Percutaneous balloon pulmonary venoplasty and drug-eluting stent placement in pulmonary vein ostia are increasingly used as palliative or bridging procedures, particularly in bilateral multi-vessel PVO not amenable to surgical revision. Outcomes with bare-metal stents have been suboptimal due to in-stent restenosis; drug-eluting stents (paclitaxel- or sirolimus-eluting) show early promise. • Hybrid approach: Combined surgical re-do and intraoperative catheter-based dilation/stenting in a hybrid cardiac catheterization/operating room suite, available at select quaternary centers. • Antifibrotic pharmacotherapy: Emerging data support adjunctive use of imatinib (a tyrosine kinase inhibitor targeting platelet-derived growth factor receptor, which drives pulmonary vein intimal proliferation) as compassionate-use therapy in refractory PVO. This is not yet standard of care but is practiced at leading centers worldwide. 4. Perioperative Adjuncts • Inhaled nitric oxide (iNO): Standard therapy for postoperative pulmonary hypertensive crises, weaned gradually over 24–72 hours as pulmonary vascular resistance normalizes. • Sildenafil (phosphodiesterase-5 inhibitor): Oral or enteral sildenafil is used to facilitate iNO weaning and to manage residual pulmonary hypertension in the postoperative period. • Milrinone: Phosphodiesterase-3 inhibitor used as inotropic and lusitropic support for left ventricular dysfunction in the early post-bypass period (left ventricle is small and relatively non-compliant after years of low filling volumes). • High-frequency oscillatory ventilation (HFOV): Reserved for refractory postoperative respiratory failure and pulmonary hypertensive crisis. • Extracorporeal membrane oxygenation (ECMO): Available at major centers as rescue therapy for postoperative cardiac or respiratory failure unresponsive to maximal medical management.
Recovery
Phase 1 — Remote Pre-Surgical Evaluation (Weeks 1–2, before travel) Families submit echocardiography reports, cardiac CT or MRI imaging, operative/discharge summaries (if prior intervention), and pediatric cardiology notes to GAF Healthcare's clinical team. A GAF-affiliated pediatric cardiac surgeon and pediatric cardiologist review all records within 48–72 hours and issue a formal surgical opinion, including subtype classification, urgency categorization (elective vs. semi-urgent vs. emergent), estimated procedural complexity, and recommended destination (India or UAE) based on center expertise and family logistics. For obstructed TAPVC presenting acutely, GAF Healthcare coordinates emergency admission directly, bypassing routine elective timelines. Phase 2 — Pre-Arrival Preparation (Week 2) GAF Healthcare assists with e-Medical Visa application for India (typically approved within 24–72 hours; valid for up to 60 days with two entries) or UAE entry visa facilitation. Flight itineraries are reviewed to ensure the infant is stable for travel; oxygen supplementation during flight is arranged if SpO2 is borderline. The family receives a pre-travel checklist: current medications (including PGE1 infusion documentation if applicable), feeding history, growth chart, allergy list, and vaccination record. Phase 3 — Hospital Admission and Preoperative Assessment (Days 1–3 in country) Upon arrival, a GAF-assigned patient coordinator meets the family at the airport and transfers them directly to the hospital. Pediatric cardiology admission workup is completed: repeat TTE/TEE, chest X-ray, ABG, full blood count, coagulation screen, metabolic panel, and anesthetic assessment. A pediatric cardiac anesthesiologist meets the family to explain anesthetic technique, DHCA risks, and neuroprotection strategy. The pediatric cardiac surgeon discusses surgical anatomy, operative plan (standard vs. sutureless technique), expected CPB and DHCA duration, and contingency plans. Informed consent is obtained with an interpreter present if required. Phase 4 — Surgical Procedure (Day 3–5 of admission) Surgery is performed under general anesthesia. Intraoperative TEE is used throughout. Median sternotomy is performed; CPB is established; DHCA (18–20°C) is induced with or without antegrade cerebral perfusion. The specific repair technique (standard or sutureless) is executed as planned. Intraoperative TEE confirms anastomotic patency, absence of residual obstruction, adequate ASD closure, and biventricular function before CPB is separated. The chest is closed; temporary epicardial pacing wires and mediastinal drains are placed. Total operative time ranges from 3 to 6 hours depending on anatomical complexity. Phase 5 — Pediatric Cardiac Intensive Care Unit (PCICU) (Days 1–7 post-surgery) The infant is admitted to the PCICU intubated and mechanically ventilated. Key management priorities include: inhaled nitric oxide for pulmonary hypertension management, milrinone infusion for left ventricular support, careful fluid balance to avoid left atrial hypertension, and management of chylothorax or pleural effusions if present. Extubation is targeted within 24–48 hours for uncomplicated cases, longer for complex or obstructed subtypes. Daily echocardiography monitors anastomotic flow and pulmonary venous gradients. Sildenafil is initiated enterally prior to iNO weaning. Parents receive daily structured updates and are encouraged toward kangaroo care once the infant is extubated and hemodynamically stable. Phase 6 — Step-Down Cardiac Ward (Days 7–14 post-surgery) Once hemodynamically stable, the infant is transferred to the cardiac step-down unit. Enteral feeding is advanced; a dietitian optimizes caloric density to support catch-up growth. Oral sildenafil, diuretics (furosemide with spironolactone), and aspirin (low-dose antiplatelet therapy) are prescribed as discharge medications. Predischarge TTE is performed to confirm unobstructed pulmonary venous drainage and ventricular function. Chest physiotherapy is provided; wound care is completed. Phase 7 — Hospital Discharge and In-Country Recovery (Weeks 3–6 post-surgery) Discharge typically occurs 10–18 days after surgery for uncomplicated cases. GAF Healthcare arranges accommodation near the hospital for the family. A formal post-discharge outpatient echocardiogram is scheduled at 2–3 weeks after discharge to screen for early PVO and evaluate left ventricular remodeling. A final fit-to-fly assessment is conducted by the surgical and cardiology team at 4–6 weeks post-surgery, confirming: SpO2 >95% on room air, stable hemodynamics off inotropes, no active pleural effusion, sternal healing confirmed clinically, and satisfactory echocardiographic result. A comprehensive medical summary, echocardiography report, operative note, and medication plan are provided for the receiving cardiologist at home. Phase 8 — Long-Term Follow-Up GAF Healthcare provides a structured telemedicine follow-up plan at 3 months, 6 months, and 12 months post-surgery. Families are counseled on warning signs of late PVO (progressive cyanosis, tachypnea, failure to thrive) and advised to schedule annual pediatric cardiology follow-up with echocardiography for a minimum of 5–10 years post-repair.
Risks to be aware of
TAPVC repair carries procedure-specific risks that families must understand before making a treatment decision. Overall in-hospital mortality ranges from 2–8% at high-volume centers for non-obstructed subtypes, rising to 8–20% for obstructed infracardiac TAPVC presenting in extremis with severe acidosis and end-organ compromise—making early presentation and rapid surgical access critical determinants of survival. The single most significant late complication is postoperative pulmonary venous obstruction (PVO), occurring in 5–18% of patients after conventional repair and requiring reintervention (surgical or catheter-based) in a substantial proportion; adoption of the sutureless technique has reduced this risk at centers where it is routinely applied. Neurological injury—including periventricular leukomalacia, seizures, and neurodevelopmental delay—is a recognized risk of deep hypothermic circulatory arrest (DHCA), though antegrade cerebral perfusion strategies and limiting circulatory arrest to under 40–45 minutes have substantially mitigated this risk; families should anticipate formal neurodevelopmental assessment at 12 and 24 months post-surgery. Postoperative pulmonary hypertensive crises can occur in the first 24–72 hours and are managed with inhaled nitric oxide, though refractory cases may require ECMO support. Other recognized complications include chylothorax (lymphatic injury during dissection of the vertical vein, occurring in 5–10% of cases and typically managed with medium-chain triglyceride feeds or octreotide), pleural effusion, arrhythmias (particularly junctional ectopic tachycardia in the early postoperative period, managed with amiodarone and active cooling), phrenic nerve injury, and wound infection. Patients with mixed TAPVC or those requiring reoperation for PVO carry higher cumulative surgical risk. Long-term, most patients with successful repair and no PVO lead normal or near-normal lives, with the majority reaching adulthood without functional limitation. Annual echocardiographic surveillance is recommended for a minimum of 5–10 years given the risk of late anastomotic stenosis and pulmonary vascular remodeling.
Why GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical coordination for international families, eliminating the administrative burden during an already stressful medical journey. Visa Facilitation — India: GAF Healthcare's visa coordination team guides families through the Indian e-Medical Visa application process, which is completed entirely online through the Indian government portal. The e-Medical Visa is typically approved within 24–72 hours, permits a 60-day stay with two entries, and can be extended through the Foreigners Regional Registration Office (FRRO) if the child's recovery requires a longer in-country stay. An e-Medical Attendant Visa is simultaneously processed for up to two accompanying family members at no additional fee through GAF's coordination. Emergency cases involving obstructed TAPVC are escalated directly to the Indian High Commission or Embassy for expedited processing. Visa Facilitation — UAE (Dubai/Abu Dhabi): Citizens of over 50 countries, including GCC nationals, EU/UK/US passport holders, and many others, receive visa-on-arrival or visa-free entry to the UAE for 30–90 days. GAF Healthcare assists families requiring advance UAE tourist or medical visas with documentation preparation and submission, and coordinates with the hospital's international patient department for invitation letters where required by the UAE immigration authority. Airport and Ground Transfers: A GAF-assigned bilingual patient coordinator meets the family on arrival at the destination airport—equipped with the child's full medical file and a pre-arranged ambulance or medical transport vehicle if the infant's clinical condition warrants it. Air-conditioned private transfers between airport, hospital, and accommodation are provided throughout the stay. Return transfer to the airport is scheduled following the fit-to-fly medical clearance. Accommodation for Attendants: GAF Healthcare pre-arranges serviced apartments or partner hotel accommodations within 1–2 km of the treating hospital for accompanying family members, at negotiated rates. Accommodation options are vetted for proximity, cleanliness, kitchen access (important for families with dietary requirements), and safe overnight access to the hospital. During the PCICU phase, one parent is typically permitted 24-hour bedside access per hospital policy; GAF coordinators advocate for this access and provide parents with hospital orientation on arrival. Medical Translation and Interpretation: Dedicated medical interpreters are available for Arabic, Russian, French, Swahili, Uzbek, Kazakh, and other languages for all clinical consultations, consent discussions, and ward interactions. Surgical consent documents and discharge summaries can be translated into the family's preferred language. GAF's clinical case managers—themselves medically trained—serve as patient advocates throughout the hospitalization, attending ward rounds where permitted and relaying information to families in accessible language. Telemedical Continuity: Following discharge and return home, GAF Healthcare's telemedicine platform enables scheduled video consultations between the treating pediatric cardiologist and the family (or their local cardiologist) at 1 month, 3 months, and 6 months post-surgery. Echocardiography reports from home-country follow-up are reviewed remotely by the surgical team and formal responses issued within 48 hours.
Common questions about Total Anomalous Pulmonary Venous Connection (TAPVC)
What is the cost of TAPVC repair in India compared to the UAE?
How long does my child and our family need to stay in the country before we can fly home?
What is the success rate of TAPVC repair, and what determines the outcome for my child?
How GAF Healthcare Assists in Choosing the Best Hospital for Total Anomalous Pulmonary Venous Connection (TAPVC) in Delhi NCR, India
Discover the Top Hospitals for Total Anomalous Pulmonary Venous Connection (TAPVC) in Delhi NCR, India
This page lists 35 accredited paediatric cardiology hospitals in Delhi NCR, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about total anomalous pulmonary venous connection (tapvc) in Delhi NCR, India
How many paediatric cardiology hospitals are listed in Delhi NCR, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there paediatric cardiology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for total anomalous pulmonary venous connection (tapvc) in Delhi NCR, India.
Contact us to report an inaccuracy on this page.